Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)

European Archives of Psychiatry and Clinical Neuroscience

Volumn 267, Issue 4, 2017, Pages 315-323

  Pelayo Terán, José María ^a,b   Gajardo Galán, Virginia Gajardo ^a,c   de la Ortiz García de la Foz, Víctor ^a,b   Martínez García, Obdulia ^a,b   Tabarés Seisdedos, Rafael ^b,d   Crespo Facorro, Benedicto ^a,b   Ayesa Arriola, Rosa ^a,b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c HOSPITAL INFANTA CRISTINA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Adherence; First episode psychosis; Longitudinal studies; Relapse; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MENTAL PATIENT; NON AFFECTIVE PSYCHOSIS; OBSERVATIONAL STUDY; ONSET AGE; PATIENT COMPLIANCE; POSITIVE SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RECURRENCE RISK; RELAPSE; SCHIZOPHRENIA; SOCIAL STATUS; MIDDLE AGED; PREDICTIVE VALUE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84992754387     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-016-0740-3     Document Type: Article

References (38)

1. Kane JM (2007) Treatment strategies to prevent relapse and encourage remission. J Clin Psychiatry 68(Suppl 1):27–30
2. Wyatt RJ (1997) Research in schizophrenia and the discontinuation of antipsychotic medications. Schizophr Bull 23:3–9
3. Wiersma D, Nienhuis FJ, Slooff CJ, Giel R (1998) Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 24:75–85
4. Lieberman J, Jody D, Geisler S et al (1993) Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 50:369–376
5. Andreasen NC, Liu D, Ziebell S et al (2013) Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am J Psychiatry 170:609–615. doi:10.1176/appi.ajp.2013.12050674
6. Amore M, Menchetti M, Tonti C et al (2008) Predictors of violent behavior among acute psychiatric patients: clinical study. Psychiatry Clin Neurosci 62:247–255. doi:10.1111/j.1440-1819.2008.01790.x
7. Hor K, Taylor M (2010) Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol 24:81–90. doi:10.1177/1359786810385490
8. Masand PS, Roca M, Turner MS, Kane JM (2009) Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim Care Companion J Clin Psychiatry 11:147–154. doi:10.4088/PCC.08r00612
9. Kane JM (2007) Treatment adherence and long-term outcomes. CNS Spectr 12:21–26
10. Hong J, Windmeijer F, Novick D et al (2009) The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study. Prog Neuropsychopharmacol Biol Psychiatry 33:835–841. doi:10.1016/j.pnpbp.2009.03.034
11. Robinson D, Woerner MG, Alvir JMJ et al (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 56:241. doi:10.1001/archpsyc.56.3.241
12. Zipursky RB, Menezes NM, Streiner DL (2014) Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review. Schizophr Res 152:408–414. doi:10.1016/j.schres.2013.08.001
13. Caseiro O, Pérez-Iglesias R, Mata I et al (2012) Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study. J Psychiatr Res 46:1099–1105. doi:10.1016/j.jpsychires.2012.05.001
14. Birchwood M, Todd P, Jackson C (1998) Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl 172:53–59
15. Mayoral-van Son J, de la Foz VO-G, Martinez-Garcia O et al (2015) Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals. J Clin Psychiatry. doi:10.4088/JCP.14m09540
16. Alvarez-Jimenez M, Priede A, Hetrick SE et al (2012) Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res 139:116–128. doi:10.1016/j.schres.2012.05.007
17. Pelayo-Terán JM, Pérez-Iglesias R, Ramírez-Bonilla M et al (2008) Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis. Early Interv Psychiatry 2:178–187. doi:10.1111/j.1751-7893.2008.00074.x
18. Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M et al (2006) A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. J Clin Psychiatry 67:1511–1521. doi:10.4088/JCP.v67n1004
19. First MB, Spitzer RL, Gibbon M, Williams JBW (2001) Structured Clinical Interview for DSM-IV Axis I disorders (clinician version). New York State Psychiatric Institute Biometrics Department, New York
20. Guy W (1976) CGI. Clinical global impression. In: Guy W (ed) ECDEU assess. Man. Psychopharmacol. Revis, pp 217–222
21. Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799–812. doi:10.2466/pr0.1962.10.3.799
22. Andreasen NC (1984) Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City
23. Andreasen NC (1983) Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, Iowa
24. Addington D, Addington J, Maticka-Tyndale E (1993) Assessing depression in schizophrenia: The Calgary depression scale. Br J Psychiatry 22:39–44
25. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435
26. Crespo-Facorro B, Pérez-Iglesias R, Mata I et al (2011) Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. J Psychiatr Res 45:763–769. doi:10.1016/j.jpsychires.2010.11.002
27. Hollingshead A, Redlich F (1958) Social class and mental illness: a community study. Wiley, New York
28. Amador XF, Flaum M, Andreasen NC et al (1994) Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry 51:826–836
29. Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8:470–484
30. van Mastrigt S, Addington J (2002) Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. J Psychiatry Neurosci 27:92–101
31. Robinson DG, Woerner MG, Alvir JM et al (1999) Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 156:544–549
32. Malla A, Norman R, Bechard-Evans L et al (2008) Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service. Psychol Med 38:1585–1593. doi:10.1017/S0033291707002656
33. Craig TKJ, Garety P, Power P et al (2004) The Lambeth Early Onset (LEO) team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ 329:1067. doi:10.1136/bmj.38246.594873.7C
34. Coldham EL, Addington J, Addington D (2002) Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 106:286–290
35. Addington DE, Patten SB, McKenzie E, Addington J (2013) Relationship between relapse and hospitalization in first-episode psychosis. Psychiatr Serv 64:796–799. doi:10.1176/appi.ps.201200440
36. Emsley R, Chiliza B, Asmal L, Harvey BH (2013) The nature of relapse in schizophrenia. BMC Psychiatry 13:50. doi:10.1186/1471-244X-13-50
37. Wunderink L, Nienhuis FJ, Sytema S et al (2007) Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry 68:654–656. doi:10.4088/JCP.v68n0502
38. Hui CL-M, Tang JY-M, Leung C-M et al (2013) A 3-year retrospective cohort study of predictors of relapse in first-episode psychosis in Hong Kong. Aust NZ J Psychiatry 47:746–753. doi:10.1177/0004867413487229